Skip to content
ClinCalc Pro
Menu
Calculators Drugs Pathways AI Dx Donate Get the App
Topical Nutritional / Scar Management

Vitamin E (Tocopherol — Topical Scar Management)

Brand names: Bio-Oil, E45 Cream, Dermatix (silicone + Vitamin E)

Topical vitamin E (tocopherol) is widely marketed and used by patients for scar improvement, applied to healed skin, though the clinical evidence for a meaningful scar benefit is limited.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Vitamin E is a lipid-soluble antioxidant that may moisturise the skin and theoretically modulate oxidative processes in healing tissue, but a defined mechanism of scar improvement is not established.

Prescribing in practice

  • Topical vitamin E can cause contact dermatitis and, in some studies, has not improved and may worsen cosmetic scar outcomes, so it is not a substitute for evidence-based scar care.
  • Apply only to intact, healed skin and discontinue if irritation develops.
  • Where active scar management is needed, prefer options supported by scar-management guidance and current prescribing references.

Monitoring

Review the scar and surrounding skin for any local reaction and reassess if there is no benefit or if irritation occurs.

Counselling the patient

  • Explain that evidence that vitamin E improves scars is weak and it can sometimes irritate the skin.
  • Advise applying only to fully healed skin and stopping if a rash develops.
  • Discuss better-supported scar treatments such as silicone if scar management is a priority.

Evidence & guidelines

Controlled studies have not demonstrated reliable scar benefit from topical vitamin E and have reported contact dermatitis, so it is not recommended as a primary scar treatment.

Reference: BAPRAS Scar Management Guidelines; International Advisory Panel on Scar Management 2014; Cochrane Review on Scar Treatments; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.

Calculators